Skip to content

A clinical study by using Agnimukh Churna with Kapitthashtak Churna in Irritable Bowel Syndrome Disease.

Two Arm Open Randomized Controlled Clinical Study Of Efficacy Of Agnimukh Churna (Gad Nigruha) With Kapitthashtak churna(Vrunda Madhav)in the clinical management of Grahani.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051671
Enrollment
60
Registered
2023-04-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K318- Other specified diseases of stomach and duodenum

Interventions

None listed

Sponsors

Dr Ankita PAtil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients between 16-60 years of all genders. 2.Patients having lakshanas of grahani. For Eg. Aruchi, Kshudhamadhya, Bahudravasaranam, Murhubaddham Murhudravam, Udardaha

Exclusion criteria

Exclusion criteria: Patients with major other diseases and who dont give consent.

Design outcomes

Primary

MeasureTime frame
To evaluate efficacy of Agnimukha churna on symptoms of Grahani as per subjective and objective assesment mentioned in the synopsisTimepoint: The improvement in the symptoms of Grahani with the help of Izumo scale will be graded at each follow up of 7th, 14th, 21st and 28th day.

Secondary

MeasureTime frame
To compare mode of action of agnimukha churna and kapitthastak churna in the management of grahani. To check the safety or Adverse effects of the drugs.Timepoint: At every follow up i.e.on 7th,14th,21st and 28th day the comparative study will be done and safety will be assesed.

Countries

India

Contacts

Public ContactDr Ankita Patil

APMs Ayurved Mahavidyalaya Sion

anayapathrikar@gmail.com08097522381

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026